È online una nuova versione di EPICLIN!

Se lo studio che stai cercando è stato avviato dopo settembre 2019, guarda su new.epiclin.it.

Trials

Area Centri attivi Pazienti arruolati
2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
Abacus 2 0 0 0 0 0 0 0 0 0 0 0 0 0 8 11 17 17
Adiuvo 43 0 0 0 0 1 3 6 19 31 43 51 63 73 79 91 91 91
ASCT-RT 23 26 66 109 155 207 277 325 383 435 481 533 536 536 538 538 538 538
Audit Ovaio 7 0 0 0 0 0 0 0 0 0 0 0 0 0 262 545 1008 1168
BonEnza 6 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16 50 72
CCANDY 6 0 0 0 0 0 0 0 0 0 0 60 137 192 218 218 218 218
COROP 1 0 0 0 0 10 466 466 466 466 466 466 466 466 466 466 466 466
DRTST 4 0 0 0 0 0 0 0 0 0 0 0 0 0 2 37 61 63
EARLY 9 0 0 0 0 0 0 0 0 0 0 0 0 0 1 11 18 18
EndoRing 7 0 0 0 0 0 0 0 0 0 0 0 1 295 951 951 951 951
ENOAPA 9 0 0 0 0 0 0 0 0 4 36 71 102 142 186 236 269 273
EPoS 3 0 0 0 0 0 0 0 0 1 1 1 1 1 7 50 62 62
EUDRACT 2004-003495-11 21 0 3 18 32 48 62 63 65 65 65 65 65 65 65 65 65 65
FIL DLCL10 27 0 0 0 0 0 0 0 0 11 24 43 65 88 112 112 112 112
FIL FLAZ12 49 0 0 0 0 0 0 0 0 9 32 66 89 113 135 153 160 160
FIL PanAL10 17 0 0 0 0 0 0 0 7 21 33 35 35 35 35 35 35 35
FIL R2-B 34 0 0 0 0 0 0 0 0 16 42 42 42 42 42 42 42 42
FIL RBAC500 43 0 0 0 0 0 0 0 0 18 51 57 57 57 57 57 57 57
FUCSAM 26 0 0 0 0 0 0 0 0 0 9 386 928 1556 1835 1835 1835 1835
FUSE 7 0 0 0 0 0 0 0 0 0 0 287 687 687 687 687 687 687
GIMURELL LLC 13 0 4 17 29 34 35 35 35 35 35 35 35 35 35 35 35 35
GIMURELL REAL07 23 0 0 0 0 9 18 39 66 66 66 66 66 66 66 66 66 66
GIMURELL ZETAL07 12 0 0 0 1 5 21 25 25 25 25 25 25 25 25 25 25 25
IIL BRIL06 22 0 0 3 36 53 53 53 53 53 53 53 53 53 53 53 53 53
IIL DLCL04 77 0 0 47 126 239 333 399 399 399 399 399 399 399 399 399 399 399
IIL FLE09 35 0 0 0 0 0 3 27 80 80 80 80 80 80 80 80 80 80
IIL HD0801 30 0 0 0 0 12 98 222 344 475 520 520 520 520 520 520 520 520
IIL HD0802 38 0 0 0 0 0 24 88 146 194 228 255 265 265 265 265 265 265
IIL HD0803 35 0 0 0 0 0 0 2 26 49 50 50 50 50 50 50 50 50
IIL LEN-DEX MCL07 14 0 0 0 0 10 33 33 33 33 33 33 33 33 33 33 33 33
IIL MCL0208 52 0 0 0 0 0 0 19 70 133 201 265 300 300 300 300 300 300
Itavision 13 0 0 0 0 0 0 0 0 0 0 0 0 0 0 793 1735 1816
LCI ADR 7 0 0 0 0 0 0 0 0 0 0 0 0 0 0 350 638 638
MDS ATO-AISSM02A 13 0 5 21 33 44 44 44 44 44 44 44 44 44 44 44 44 44
MDS DECI2009-AISSM06 19 0 0 0 0 0 0 19 43 43 43 43 43 43 43 43 43 43
MDS EPO2006-AISSM04 9 0 0 0 2 32 55 71 71 71 71 71 71 71 71 71 71 71
MDS Registro 115 910 1037 1185 1292 1436 1617 1938 2434 3042 3613 4106 4515 4810 5146 5431 5968 5980
MWA vs SABR 2 0 0 0 0 0 0 0 0 0 0 0 0 3 4 4 4 4
NAC-GC-01 4 0 0 0 0 0 0 0 2 2 2 2 2 2 2 2 2 2
Osteo-REC 10 0 0 0 0 0 0 0 0 2 5 8 8 8 8 8 8 8
Osteo-REC 2015 9 0 0 0 0 0 0 0 0 0 0 0 0 3 5 7 7 7
PON-PC-02 28 1 1 1 1 1 1 12 69 140 183 199 199 199 199 199 199 199
Registro LMC GIMEMA 68 0 0 0 0 1 1 1 1 16 47 107 488 1205 1705 2118 2272 2393
Studio GDM 1 0 0 0 0 0 23 70 177 200 200 200 200 200 200 200 200 200
Studio H2WL 1 0 0 0 0 0 0 0 0 0 0 0 69 120 120 120 120 120
Studio Resveratrolo 1 0 0 0 0 0 0 0 0 0 32 125 192 192 192 192 192 192
Studio TOTEM 44 0 0 0 0 5 107 329 547 775 987 1150 1349 1556 1773 1884 1884 1884
Study ML17638: Rituximab 33 19 98 158 235 235 235 235 235 235 235 235 235 235 235 235 235 235
TRANSLATE colon-retto 2 0 0 0 0 0 0 0 0 0 0 0 0 4 4 4 4 4
TRANSLATE mammella 2 0 0 0 0 0 0 0 0 0 0 0 0 5 6 7 7 7
TRANSLATE prostata 2 0 0 0 0 0 0 0 0 0 0 0 0 3 3 4 4 4
TRANSLATE rene 2 0 0 0 0 0 0 0 0 0 0 0 0 0 2 3 4 4